Guanze Medical Information Industry (Holding) Co., Ltd.
HHKEX:24272.80
HKD
-0.02
(-0.71%)
ISIN
KYG4315D1060
CUSIP
G4315D106
Return %
Stock
S&P 500
1Y
408.18
14.20
3Y
787.30
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Zeman Jiang
- Full Time Employees
- 56
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Strategic Emerging Industry Base Shandong SD China
- IPO Date
- Dec 29, 2022
- Website
- unifull.com
- Similar Companies
- Business
- Guanze Medical Information Industry (Holding) Co., Ltd. engages in the provision of medical imaging solutions in the People's Republic of China, with a focus on medical imaging film products and cloud-based imaging services. The company operates as an investment holding entity, with core activities centered on the research, development, sale, and maintenance of medical imaging materials and associated information technology platforms. Headquartered in Jinan, China, Guanze maintains a corporate structure that includes subsidiaries dedicated to manufacturing and distributing imaging films, as well as delivering cloud-based medical imaging solutions and related digital platforms. The firm markets imaging films to hospitals and healthcare institutions, while also offering digital medical imaging cloud storage platforms, digital image platforms, regional imaging diagrams platforms, and Picture Archiving and Communication System (PACS) solutions. Additional revenue streams arise from the sale of self-service film output printers, medical image printers, and data distribution systems, alongside maintenance and leasing of medical devices. The company’s operations span across China, with strategic emphasis on expanding market presence in Shandong Province and broader eastern regions, leveraging brand promotion, industry exhibitions, and IT system upgrades to enhance service delivery. Guanze was founded in 2015 and is publicly listed on the Hong Kong Stock Exchange (ticker: 2427.HK), with a corporate headquarters in Jinan and an implied corporate structure that includes a Cayman Islands entity as the primary holding vehicle. The company’s geographic footprint includes mainland China operations and related regional service networks, aiming to serve hospitals, clinics, and other healthcare providers with integrated imaging film products and cloud-based imaging services. The latest major changes include strategic expansions in product offerings and value chain development, ongoing acquisitions and registrations to broaden device capabilities, and initiatives to upgrade IT systems and broaden market reach through exhibitions and brand initiatives.